Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: JT - Shareholder Letter

Make sure that you refer to the Patent Reform Act of 2007 when you address your concerns.

 

Apparently there is already a separate S 1145 on the floor. 

Share
New Message
Please login to post a reply